Ocular TherapeutixOCUL
13F holders, Q1 2025 (March 31)196holders +17
33new positions
17sold out
6famous investors
$7.33avg. 13F price*
At the end of Q1 2025, 196 institutions reported holding Ocular Therapeutix Inc. (OCUL) in their 13F filings, up 17 from Q4 2024. 33 opened new positions and 17 sold out. The largest holders were Deep Track Capital, LP ($104.8M), Summer Road LLC ($101.7M) and Venrock Adviser, LLC ($93.5M). 6 famous investors held it, including Steve Cohen (0.0% of Point72 Asset Management's portfolio), Ken Griffin (0.0% of Citadel Advisors's portfolio) and Paul Tudor Jones (0.0% of Tudor Investment Corporation's portfolio).
- Company
- Ocular Therapeutix Inc.
- CUSIP
- 67576A100
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 33 | $32.4M |
| Exits | 17 | $13.1M |
All 13F filers, Q4 2024 → Q1 2025: 12,930,876 shares bought and 9,445,049 shares sold, net +3,485,827 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 196 holders
| Deep Track Capital, LP | 3.39% | Add +11.4% | 14,294,420 | $104.8M |
| Summer Road LLC | 98.23% | Add +0.1% | 13,878,018 | $101.7M |
| Venrock Adviser, LLC | 7.96% | No change | 12,762,462 | $93.5M |
| BlackRock, Inc. | 0.00% | Add +1.4% | 12,012,397 | $88.1M |
| Vanguard Group Inc. | 0.00% | Reduce -1.4% | 8,364,515 | $61.3M |
| Avoro Capital Advisors LLC | 0.92% | No change | 8,060,000 | $59.1M |
| TCG Crossover Management, LLC | 5.32% | No change | 5,319,148 | $39.0M |
| Adage Capital Partners Gp, L.L.C. | 0.07% | Add +44.4% | 5,200,000 | $38.1M |
| Citadel Advisors | 0.04% | Add +8.0% | 4,811,108 | $35.3M |
| Geode Capital Management, LLC | 0.00% | Add +5.8% | 3,422,412 | $25.1M |
| State Street Corp. | 0.00% | Reduce -2.8% | 3,391,850 | $24.9M |
| Deltec Asset Management LLC | 4.28% | Add +3.8% | 2,716,373 | $19.9M |
| Octagon Capital Advisors LP | 3.86% | No change | 2,425,000 | $17.8M |
| Logos Global Management LP | 3.00% | Reduce -34.3% | 2,300,000 | $16.9M |
| Morgan Stanley | 0.00% | Add +20.1% | 2,188,478 | $16.0M |
| Point72 Asset Management | 0.04% | Reduce -33.8% | 1,942,362 | $14.2M |
| Opaleye Management Inc. | 2.67% | Reduce -63.3% | 1,595,000 | $11.7M |
| UBS Group AG | 0.00% | Add +52.3% | 1,334,939 | $9.8M |
| Paradigm Biocapital Advisors LP | 0.44% | New | 1,314,018 | $9.6M |
| Northern Trust Corp. | 0.00% | Reduce -1.8% | 1,290,917 | $9.5M |
| Acuta Capital Partners, LLC | 10.37% | Add +9.8% | 1,219,724 | $8.9M |
| Rosalind Advisors, Inc. | 4.35% | Add +8.0% | 1,218,700 | $8.9M |
| Franklin Resources Inc. | 0.00% | Add +0.0% | 1,170,259 | $8.6M |
| Artisan Partners Limited Partnership | 0.01% | Reduce -13.5% | 1,155,076 | $8.5M |
| Charles Schwab Investment Management Inc. | 0.00% | Reduce -1.6% | 1,112,793 | $8.2M |
| Bank of America Corp. | 0.00% | Add +115.6% | 942,288 | $6.9M |
| FMR LLC | 0.00% | Add +104.4% | 941,294 | $6.9M |
| Patient Square Capital LP | 2.79% | Add +95.4% | 920,199 | $6.7M |
| Perceptive Advisors LLC | 0.24% | Reduce -15.1% | 915,775 | $6.7M |
| Peregrine Capital Management LLC | 0.21% | New | 847,468 | $6.2M |
| Invesco Ltd. | 0.00% | Reduce -9.6% | 804,829 | $5.9M |
| Woodline Partners LP | 0.04% | Reduce -25.1% | 750,950 | $5.5M |
| Cetera Investment Advisers | 0.01% | Reduce -0.3% | 721,364 | $5.3M |
| Knoll Capital Management, LLC | 2.86% | No change | 600,400 | $4.4M |
| Saturn V Capital Management LP | 2.21% | Add +212.4% | 598,191 | $4.4M |
| Goldman Sachs Group Inc. | 0.00% | Reduce -13.5% | 582,009 | $4.3M |
| AXA S.A. | 0.01% | Reduce -12.3% | 559,519 | $4.1M |
| Silverarc Capital Management, LLC | 0.84% | New | 551,570 | $4.0M |
| Barclays PLC | 0.00% | Add +49.5% | 495,236 | $3.6M |
| Two Sigma Investments, LP | 0.01% | Add +82.3% | 461,230 | $3.4M |
| Renaissance Technologies | 0.01% | New | 454,000 | $3.3M |
| Wellington Management Group LLP | 0.00% | Reduce -3.1% | 452,964 | $3.3M |
| Susquehanna International Group, LLP | 0.01% | Add +293.3% | 439,444 | $3.2M |
| Pale Fire Capital SE | 0.39% | Reduce -1.2% | 439,387 | $3.2M |
| Bank of New York Mellon Corp | 0.00% | Reduce -0.2% | 419,493 | $3.1M |
| Nuveen, LLC | 0.00% | — | 414,104 | $3.0M |
| Essex Investment Management Co. LLC | 0.59% | Reduce -0.8% | 384,325 | $2.8M |
| Raymond James Financial Inc. | 0.00% | Add +80.7% | 364,243 | $2.7M |
| Second Line Capital, LLC | 0.65% | Add +1.8% | 346,098 | $2.5M |
| Aptus Capital Advisors, LLC | 0.03% | Add +1.9% | 346,098 | $2.5M |
| Assenagon Asset Management S.A. | 0.00% | New | 341,800 | $2.5M |
| JPMorgan Chase & Co. | 0.00% | Add +78.5% | 337,831 | $2.5M |
| Voya Investment Management LLC | 0.00% | Reduce -9.3% | 336,516 | $2.5M |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 0.05% | Reduce -4.5% | 258,363 | $1.9M |
| Deutsche Bank AG | 0.00% | Reduce -43.4% | 258,225 | $1.9M |
| Macquarie Group Ltd. | 0.00% | Add +2222.6% | 244,984 | $1.8M |
| Erste Asset Management GmbH | 0.02% | No change | 235,800 | $1.8M |
| Rhumbline Advisers | 0.00% | Add +4.5% | 223,115 | $1.6M |
| Panagora Asset Management Inc. | 0.01% | Reduce -49.3% | 222,004 | $1.6M |
| First Trust Advisors LP | 0.00% | Add +2.4% | 217,970 | $1.6M |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 0.00% | Reduce -2.6% | 212,952 | $1.6M |
| State of Wisconsin Investment Board | 0.00% | Add +10.4% | 199,030 | $1.5M |
| RoundAngle Advisors LLC | 1.32% | Reduce -1.3% | 195,875 | $1.4M |
| Banco Santander, S.A. | 0.01% | Add +21.8% | 184,048 | $1.3M |
| Swiss National Bank | 0.00% | No change | 184,000 | $1.3M |
| Alliancebernstein L.P. | 0.00% | No change | 162,820 | $1.2M |
| Courier Capital LLC | 0.07% | Add +173.3% | 154,266 | $1.1M |
| Sei Investments Co. | 0.00% | Add +420.3% | 144,349 | $1.1M |
| Cubist Systematic Strategies, LLC | 0.01% | New | 137,871 | $1.0M |
| Citigroup Inc. | 0.00% | Reduce -13.8% | 131,987 | $967K |
| T. Rowe Price Associates Inc. | 0.00% | Reduce -80.3% | 125,741 | $922K |
| Stempoint Capital LP | 0.29% | New | 124,523 | $913K |
| Intech Investment Management LLC | 0.01% | Add +14.3% | 113,597 | $833K |
| Legato Capital Management LLC | 0.11% | Reduce -1.5% | 113,090 | $829K |
| Jane Street Group, LLC | 0.00% | New | 105,049 | $770K |
| Legal & General Group Plc | 0.00% | Reduce -0.4% | 104,403 | $765K |
| DekaBank Deutsche Girozentrale | 0.00% | No change | 100,000 | $746K |
| New York State Common Retirement Fund | 0.00% | No change | 98,097 | $719K |
| ExodusPoint Capital Management, LP | 0.01% | New | 96,185 | $705K |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 0.00% | Add +5.8% | 93,619 | $686K |
| MetLife Investment Management, LLC | 0.00% | Add +0.7% | 93,397 | $685K |
| California State Teachers Retirement System | 0.00% | No change | 91,998 | $674K |
| Brown Advisory Inc. | 0.00% | No change | 90,000 | $660K |
| HighVista Strategies LLC | 0.24% | No change | 85,241 | $625K |
| Canada Pension Plan Investment Board | 0.00% | Add +10125.0% | 81,800 | $600K |
| Tudor Investment Corporation | 0.01% | New | 79,648 | $584K |
| Corebridge Financial, Inc. | 0.00% | Add +0.1% | 77,460 | $568K |
| Wells Fargo & Company | 0.00% | Add +3.8% | 77,045 | $565K |
| Balyasny Asset Management L.P. | 0.00% | Reduce -22.2% | 75,869 | $556K |
| Two Sigma Advisers, LP | 0.00% | Add +99.2% | 73,100 | $536K |
| Manufacturers Life Insurance Company, The | 0.00% | Reduce -44.2% | 71,304 | $523K |
| Verition Fund Management LLC | 0.00% | New | 70,430 | $516K |
| Ameriprise Financial Inc. | 0.00% | Reduce -24.1% | 68,145 | $500K |
| D. E. Shaw & Co. | 0.00% | Add +91.4% | 60,123 | $441K |
| Polar Asset Management Partners Inc. | 0.02% | Reduce -85.6% | 56,670 | $415K |
| Janus Henderson Group PLC | 0.00% | No change | 53,500 | $405K |
| BNP Paribas Financial Markets | 0.00% | Reduce -27.7% | 54,483 | $399K |
| Grant/GrossMendelsohn, LLC | 0.22% | No change | 47,691 | $388K |
| Truist Financial Corp. | 0.00% | No change | 50,000 | $367K |
| Simplex Trading, LLC | 0.01% | Reduce -46.5% | 49,962 | $366K |
"% of holder's portfolio" is OCUL's weight in each manager's 13F, not the share of Ocular Therapeutix Inc. the manager owns.